1 year return (CAGR)
-43.23%
Larimar Therapeutics Inc Exchange (NASDAQ, USD)
LRMR
2.39
+0.15 (+6.70%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-6.46%
5 year return (CAGR)
-27.73%
10 year return (CAGR)
-24.66%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
248.28M
Price/Sales
-
Ent value
193.51M
Price/Book
1.95
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-8.67%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.25 |
| Daily high | 2.41 |
| Daily low | 2.21 |
| Daily Volume | 1.20M |
| All-time high | 616.08 |
| 1y analyst estimate | 14.40 |
| Beta | 0.75 |
| EPS (TTM) | -1.66 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| LRMR | S&P500 | |
| Current price drop from All-time high | -99.61% | -1.21% |
| Highest price drop | -99.75% | -56.47% |
| Date of highest drop | 5 Aug 2022 | 9 Mar 2009 |
| Avg drop from high | -87.01% | -10.65% |
| Avg time to new high | 104 days | 12 days |
| Max time to new high | 2920 days | 1805 days |
News
